3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
9
Lymphoma, Mantle-Cell
8
Breast Neoplasms
7
Lymphoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, T-Cell
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma, B-Cell
5
Recurrence
4
Neuroblastoma
4
Myelodysplastic Syndromes
4
Mycosis Fungoides
4
Multiple Myeloma
4
Lymphoma, T-Cell, Cutaneous
4
Leukemia
4
Congenital Abnormalities
4
Carcinoma, Non-Small-Cell Lung
4
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Erythroblastic, Acute
3
Glioblastoma
3
Burkitt Lymphoma
3
Interventions
eltrombopag
6
romiplostim
4
avatrombopag
4
Cytarabine
4
Daunorubicin
3
Cyclophosphamide
3
oprelvekin
2
hetrombopag
2
Tretinoin
2
Tranexamic Acid
2
Radiotherapy
2
Platelet Transfusion
2
Filgrastim
2
Etoposide
2
Carboplatin
2
sodium thiosulfate
1
raltitrexed
1
pegfilgrastim
1
ofatumumab
1
niraparib
1
leridistim
1
fludarabine
1
etoposide phosphate
1
angiotensin I (1-7)
1
Vorinostat
1
Vincristine
1
Thioguanine
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Thrombocytopenia
×
Vorinostat
×
Clear all
NCT01500538
2016-02-15
VEIL
Peter MacCallum Cancer Centre, Australia
Phase 2
Terminated
1 enrolled